BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Dec 12, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Cobas 4800 BRAF V600 Mutation Test regulatory update

Roche said Health Canada approved its cobas 4800 BRAF V600 Mutation Test to identify patients with metastatic melanoma tumors with a mutation in the BRAF gene. The PCR-based...

Read the full 120 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >